BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 5.1.4//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Truth or Consequences-To vaccinate or not Paul Klotman\, M.D.\,
  FACP Baylor College of Medicine President & CEO Since September 1\, 2010 
 I have had the privilege of serving as President and CEO of Baylor College
  of Medicine\, one of the world’s leading health science universities. M
 y position as the leader of Baylor College of Medicine has highlighted to 
 me the need for radical change in academic medicine. Through the applicati
 on of scientific principles across all areas of the College\, we are creat
 ing new models for how we manage and operate the College\; deliver care fo
 cused on value and on the individual\; and conduct research. As we develop
  these new models we are changing the way we educate the next generation s
 o that they will be prepared\, not only to work with new approaches\, but 
 to continue to evolve our models for changing times. We are redefining aca
 demic medicine. In the laboratory my work has blended both basic and clini
 cal research in molecular virology and AIDS pathogenesis. I have mentored 
 over 50 clinical fellows\, postdoctoral fellows\, and students in my labor
 atory\, most of whom are now independently funded\, including four who cur
 rently serve as chairs of medicine and four others who lead major institut
 es or centers. Among other achievements\, the work in my laboratory\, led 
 to development of the first small animal model of HIV-associated nephropat
 hy using transgenic techniques. Throughout my career\, enhancing medical e
 ducation has been a driving force. As Chairman of Medicine at Mount Sinai 
 School of Medicine I led a redesign of the residency program that helped m
 ake it one of the top internal medicine programs in the country. At Baylor
 \, I am working with the leadership of all four schools to strengthen and 
 expand medical and scientific education from kindergarten through post-gra
 duate training. Ultimately the goal of all we are doing at Baylor is to im
 prove the health and wellbeing of the people of Houston and the world. Ach
 ieving this requires engagement in the world outside academia to shape and
  encourage adoption of new policies. Toward this end\, I work with our loc
 al and national governments as well as Baylor’s affiliated institutions 
 and serve on many local and national boards and committees\, including the
  Greater Houston Partnership\, the American Association of Medical College
 s\, and the boards of several companies. 
DTEND:20251120T190000Z
DTSTAMP:20260913T170904Z
DTSTART:20251120T173000Z
LOCATION:Tony's
SEQUENCE:1
SUMMARY:Vaccines/Medication/Autism - Paul Klotman M.D.
UID:5d00960f-5da3-4181-b79b-c4e1e489202e
X-ALT-DESC;FMTTYPE=text/html:<p><span style="font-size:18px\;"><strong>Trut
 h or Consequences-To vaccinate or not</strong></span></p>\n\n<p><br />\n<s
 pan style="font-size:14px\;"><strong>Paul Klotman\, M.D.\, FACP<br />\nBay
 lor College of Medicine<br />\nPresident &amp\; CEO</strong></span></p>\n\
 n<p><span style="font-size:12px\;"><span style="font-family: &quot\;Noto S
 ans&quot\;\, sans-serif\;">Since September 1\, 2010 I have had the privile
 ge of serving as President and CEO of Baylor College of Medicine\, one of 
 the world&rsquo\;s leading health science universities.</span><br style="b
 ox-sizing: border-box\; font-family: &quot\;Noto Sans&quot\;\, sans-serif\
 ; font-size: 16px\;" />\n<br />\n<span style="font-family: &quot\;Noto San
 s&quot\;\, sans-serif\;">My position as the leader of Baylor College of Me
 dicine has highlighted to me the need for radical change in academic medic
 ine. Through the application of scientific principles across all areas of 
 the College\, we are creating new models for how we manage and operate the
  College\; deliver care focused on value and on the individual\; and condu
 ct research. As we develop these new models we are changing the way we edu
 cate the next generation so that they will be prepared\, not only to work 
 with new approaches\, but to continue to evolve our models for changing ti
 mes. We are redefining academic medicine.</span><br style="box-sizing: bor
 der-box\; font-family: &quot\;Noto Sans&quot\;\, sans-serif\; font-size: 1
 6px\;" />\n<br style="box-sizing: border-box\; font-family: &quot\;Noto Sa
 ns&quot\;\, sans-serif\; font-size: 16px\;" />\n<span style="font-family: 
 &quot\;Noto Sans&quot\;\, sans-serif\;">In the laboratory my work has blen
 ded both basic and clinical research in molecular virology and AIDS pathog
 enesis. I have mentored over 50 clinical fellows\, postdoctoral fellows\, 
 and students in my laboratory\, most of whom are now independently funded\
 , including four who currently serve as chairs of medicine and four others
  who lead major institutes or centers. Among other achievements\, the work
  in my laboratory\, led to development of the first small animal model of 
 HIV-associated nephropathy using transgenic techniques.</span><br style="b
 ox-sizing: border-box\; font-family: &quot\;Noto Sans&quot\;\, sans-serif\
 ; font-size: 16px\;" />\n<br style="box-sizing: border-box\; font-family: 
 &quot\;Noto Sans&quot\;\, sans-serif\; font-size: 16px\;" />\n<span style=
 "font-family: &quot\;Noto Sans&quot\;\, sans-serif\;">Throughout my career
 \, enhancing medical education has been a driving force. As Chairman of Me
 dicine at Mount Sinai School of Medicine I led a redesign of the residency
  program that helped make it one of the top internal medicine programs in 
 the country. At Baylor\, I am working with the leadership of all four scho
 ols to strengthen and expand medical and scientific education from kinderg
 arten through post-graduate training.</span><br style="box-sizing: border-
 box\; font-family: &quot\;Noto Sans&quot\;\, sans-serif\; font-size: 16px\
 ;" />\n<br style="box-sizing: border-box\; font-family: &quot\;Noto Sans&q
 uot\;\, sans-serif\; font-size: 16px\;" />\n<span style="font-family: &quo
 t\;Noto Sans&quot\;\, sans-serif\;">Ultimately the goal of all we are doin
 g at Baylor is to improve the health and wellbeing of the people of Housto
 n and the world. Achieving this requires engagement in the world outside a
 cademia to shape and encourage adoption of new policies. Toward this end\,
  I work with our local and national governments as well as Baylor&rsquo\;s
  affiliated institutions and serve on many local and national boards and c
 ommittees\, including the Greater Houston Partnership\, the American Assoc
 iation of Medical Colleges\, and the boards of several companies.</span></
 span></p>\n
END:VEVENT
END:VCALENDAR